Cargando…
Curative resection of a primarily unresectable acinar cell carcinoma of the pancreas after chemotherapy
BACKGROUND: Acinar cell carcinoma (ACC) represents only 1–2% of pancreatic cancers and is a very rare malignancy. At the time of diagnosis only 50% of the tumors appear to be resectable. Reliable data for an effective adjuvant or neoadjuvant treatment are not available. CASE PRESENTATION: A 65-year...
Autores principales: | Distler, Marius, Rückert, Felix, Dittert, Dag D, Stroszczynski, Christian, Dobrowolski, Frank, Kersting, Stephan, Grützmann, Robert |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2009
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2657786/ https://www.ncbi.nlm.nih.gov/pubmed/19239719 http://dx.doi.org/10.1186/1477-7819-7-22 |
Ejemplares similares
-
Evaluation of survival in patients after pancreatic head resection for ductal adenocarcinoma
por: Distler, Marius, et al.
Publicado: (2013) -
Chronic pancreatitis of the pancreatic remnant is an independent risk factor for pancreatic fistula after distal pancreatectomy
por: Distler, Marius, et al.
Publicado: (2014) -
Induction Chemotherapy for Primarily Unresectable Locally Advanced Pancreatic Adenocarcinoma—Who Will Benefit from a Secondary Resection?
por: Rosumeck, Nathalie, et al.
Publicado: (2021) -
Acinar Cell Cystadenocarcinoma of the Pancreas
por: Aoto, Keita, et al.
Publicado: (2017) -
A resected case of acinar cell carcinoma of the pancreas with liver metastasis following chemotherapy using modified FOLFIRINOX
por: Yamada, Shuhei, et al.
Publicado: (2023)